Magnesium 관련 대사증후군

B 근거 적어도 하나의 무작위 시험이 이를 지지하며, 대체로 일관된 결과를 보입니다.

Meta-analysis of 32 RCTs (n=2,382) found significant reductions in BMI, waist circumference, fasting glucose, and CRP. Each 100 mg/day increase in magnesium intake was associated with 5% lower metabolic syndrome risk. Up to 68% of Americans fail to meet the RDA.

𝕏 LinkedIn

<\/script>\n

`; }, get iframeSnippet() { const domain = 'weightcited.com'; const params = 'ingredient\u003Dmagnesium\u0026condition\u003Dmetabolic\u002Dsyndrome'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style

Widget powered by . Free, no account required.

결론

Key Study Findings

Observational Study n=155

Intake of fiber and micronutrients in patients with IBS.

Dose: None vs: None Outcome: Fiber and micronutrient intake in IBS patients 효과: 91% low fiber; 85.8% low vitamin D None

대상 집단: IBS patients (Rome IV), 83.9% women, median 42 years

Case Reports 13.0 weeks

A case report of Gitelman syndrome in children.

Dose: 3 g vs: None Outcome: pain reduction 효과: None None

대상 집단: Hypokalemia

Review

Consequences of Disturbing Manganese Homeostasis.

Dose: Manganese (Mn) - exposure assessment vs: None Outcome: Mn toxicity mechanisms on CNS 효과: None None

대상 집단: General (manganese exposure review)

Review

Metabolic Characteristics of Hashimoto's Thyroiditis Patients and the Role of Microelements and Diet in the …

Dose: None vs: None Outcome: Thyroid function and autoantibody levels 효과: None None

대상 집단: Hashimoto thyroiditis patients

Other

[Nutrition in the prevention and healing of chronic wounds. Importance in improving the diabetic foot].

Dose: None vs: None Outcome: None 효과: None None

대상 집단: chronic wounds and have been linked to delayed wound healing and dehiscence

Cohort Study n=1107

Prevalence and associated risk factors of periodic limb movement in sleep in two German population-based …

Dose: None vs: None Outcome: None 효과: OR = 2.20 None

대상 집단: None

Key Statistics

연구

2382

참여자

↑

Positive

등급

Referenced Papers

A Comprehensive Review of Nutritional Influences on the Serotonergic System. Review

Advances in nutrition … 2025 5 인용

Intake of fiber and micronutrients in patients with IBS. Other

Scandinavian journal of … 2025

Consequences of Disturbing Manganese Homeostasis. Review

International journal of … 2023 120 인용

A case report of Gitelman syndrome in children. Case Report

Medicine 2023

Metabolic Characteristics of Hashimoto's Thyroiditis Patients and the Role of Microelements and Diet in the Disease Management-An Overview. Review

International journal of … 2022 102 인용

[Nutrition in the prevention and healing of chronic wounds. Importance in improving the diabetic foot]. Other

Nutricion hospitalaria 2021 20 인용

Prevalence and associated risk factors of periodic limb movement in sleep in two German population-based studies. Other

Sleep 2019 38 인용

Evaluation of Dietary Intakes and Supplement Use in Paralympic Athletes. Other

Nutrients 2017 46 인용

[Restless legs syndrome and periodic limb movements during sleep in a patient with obstructive sleep apnea]. Other

Neurologia i neurochirurgia … 2004 2 인용

Magnesium, zinc, and chromium nutriture and physical activity. Review

The American journal … 2000 207 인용

Effects of spironolactone on serum and muscle electrolytes in patients on long-term diuretic therapy for congestive heart failure and/or arterial … RCT

European journal of … 1986 22 인용

Depression or asthenia related to metabolic disturbances in obese patients after intestinal bypass surgery. Other

Acta psychiatrica Scandinavica 1979 22 인용

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

일반적으로 사용되는 용량

general:: 310-420 mg/day (RDA)
sleepsupport:: 200-400 mg glycinate before bed
weightmanagement:: 250-500 mg elemental magnesium/day

상한량: 350 mg/day from supplements only (laxative effect); no UL from food sources

연구에서 사용된 용량

용량	기간	효과	N
None	--	Negative	155
3 g	13.0 weeks	Mixed	--
Manganese (Mn) - exposure assessment	--	Negative	--
None	--	Positive	--
None	--	Positive	--
None	--	Mixed	1107
None	--	Mixed	40
None	--	Mixed	1

권장 복용 시간: Evening (glycinate/threonate for sleep); with meals (citrate) to reduce GI effects

Safety & Side Effects

보고된 부작용

⚠ Diarrhea (especially oxide form)
⚠ Nausea
⚠ Abdominal cramping
⚠ Low blood pressure (at very high doses)

알려진 상호작용

● Antibiotics (reduced absorption — take 2 hours apart)
● Bisphosphonates (reduced absorption)
● Diuretics (may increase or decrease levels)
● Proton pump inhibitors (may deplete magnesium)

일일 최대 섭취 허용량: 350 mg/day from supplements only (laxative effect); no UL from food sources

건강기능식품을 복용하기 전에 반드시 의료 전문가와 상담하십시오.

Frequently Asked Questions

Does Magnesium help with 대사증후군?

Based on 32 studies with 2,382 participants, there is moderate evidence from clinical studies that Magnesium may support 대사증후군 management. Our evidence grade is B (Good Evidence).

How much Magnesium should I take for 대사증후군?

Studies have used various dosages. A commonly studied range is 310-420 mg/day (RDA). Always consult your healthcare provider before starting any supplement regimen.

Are there side effects of Magnesium?

Reported side effects may include Diarrhea (especially oxide form), Nausea, Abdominal cramping, Low blood pressure (at very high doses). Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.

How strong is the evidence for Magnesium and 대사증후군?

We rate the evidence as Grade B (Good Evidence). This rating is based on 32 peer-reviewed studies with 2,382 total participants. The overall direction of effect is positive.

Magnesium 다른 건강 상태에 대한 근거

인슐린 저항성 B

한눈에 보기

Evidence Strength72%

High confidence

연구 분석

RCT (1)Meta (0)Other (31)

대안 비교

이 건강 상태에 대한 다른 성분의 비교 결과를 확인하세요.

모든 성분 보기: 대사증후군

자세히 알아보기

References

[1] Justin Tang et al.. Adv Nutr. 2025. A Comprehensive Review of Nutritional Influences on the Serotonergic System. doi:10.1016/j.advnut.2025.100524 PubMed
[2] Bodil Roth et al.. Scand J Gastroenterol. 2025. Intake of fiber and micronutrients in patients with IBS. doi:10.1080/00365521.2025.2535721 PubMed
[3] Jacek Baj et al.. Int J Mol Sci. 2023. Consequences of Disturbing Manganese Homeostasis. doi:10.3390/ijms241914959 PubMed
[4] Jing Ying et al.. Medicine (Baltimore). 2023. A case report of Gitelman syndrome in children. doi:10.1097/MD.0000000000033509 PubMed
[5] Aniceta A Mikulska et al.. Int J Mol Sci. 2022. Metabolic Characteristics of Hashimoto's Thyroiditis Patients and the Role of Microelements and Diet in the Disease Management-An Overview. doi:10.3390/ijms23126580 PubMed
[6] Rosa María Martínez García et al.. Nutr Hosp. 2021. [Nutrition in the prevention and healing of chronic wounds. Importance in improving the diabetic foot]. doi:10.20960/nh.03800 PubMed
[7] András Szentkirályi et al.. Sleep. 2019. Prevalence and associated risk factors of periodic limb movement in sleep in two German population-based studies. doi:10.1093/sleep/zsy237 PubMed
[8] Robyn F Madden et al.. Nutrients. 2017. Evaluation of Dietary Intakes and Supplement Use in Paralympic Athletes. doi:10.3390/nu9111266 PubMed
[9] Luiza Jonczak et al.. Neurol Neurochir Pol. 2004. [Restless legs syndrome and periodic limb movements during sleep in a patient with obstructive sleep apnea]. PubMed
[10] H C Lukaski. Am J Clin Nutr. 2000. Magnesium, zinc, and chromium nutriture and physical activity. doi:10.1093/ajcn/72.2.585S PubMed
[11] T Dyckner et al.. Eur J Clin Pharmacol. 1986. Effects of spironolactone on serum and muscle electrolytes in patients on long-term diuretic therapy for congestive heart failure and/or arterial … doi:10.1007/BF00542411 PubMed
[12] P Bech et al.. Acta Psychiatr Scand. 1979. Depression or asthenia related to metabolic disturbances in obese patients after intestinal bypass surgery. doi:10.1111/j.1600-0447.1979.tb00245.x PubMed

FDA 면책 조항: 이 내용은 미국 식품의약국(FDA)의 평가를 받지 않았습니다. 이 웹사이트의 제품 및 정보는 질병의 진단, 치료, 완치 또는 예방을 목적으로 하지 않습니다. 제시된 근거 등급은 발표된 동료 심사 연구에 대한 우리의 분석에 기반하며, 의학적 조언을 구성하지 않습니다. 건강기능식품 복용을 시작하기 전에 반드시 의료 전문가와 상담하십시오.